Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cells.

Saved in:
Bibliographic Details
Title: Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cells.
Authors: Yankelevich M; St. Christopher's Hospital for Children, Drexel University., Thakur A; University of Virginia., Modak S; Memorial Sloan Kettering Cancer Center., Chu R; Children's Hospital of Michigan (CHM), Wayne State University., Taub J; Children's Hospital of Michigan (CHM), Wayne State University., Martin A; Children's Hospital of Michigan (CHM), Wayne State University., Schalk DL; University of Virginia., Schienshang A; University of Virginia., Whitaker S; University of Virginia., Rea K; University of Virginia., Lee DW; University of Virginia., Liu Q; Wistar Institute., Shields A; Karmanos Cancer Institute and Wayne State University., Cheung NK; Memorial Sloan Kettering Cancer Center., Lum LG; University of Virginia.
Source: Research square [Res Sq] 2023 Nov 09. Date of Electronic Publication: 2023 Nov 09.
Publication Type: Preprint; Journal Article
Journal Info: Country of Publication: United States NLM ID: 101768035 Publication Model: Electronic Cited Medium: Internet ISSN: 2693-5015 (Electronic) Linking ISSN: 26935015 NLM ISO Abbreviation: Res Sq Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2693-5015
DOI:10.21203/rs.3.rs-3570311/v1